Drugs / Levamisole
Levamisole
also known as
levamisole hydrochloride · Ascaridil · Ergamisol · Ketrax · L-narpenol · LEV · levamisol · Levamisole hcl · +7 more
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | ERGAMISOL | — | 1990-06-18 | fda.gov ↗ |
Trials 19 · a red edge is where a trial was stopped
Also used as a comparator or background therapy in 5 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 33 trials | ||||||
| Phase 3 | NCT04360122 Comparator | May → Nov 2020 | COVID-19 | Ain Shams University | Unknown | No outcome recorded |
| Phase 3 | NCT04383717 Comparator | May → Aug 2020 | respiratory tract infectious disorder | Cairo University | Unknown | No outcome recorded |
| Phase 3 | NCT00002593 Comparator | Dec 1994 → Dec 1999 | colorectal cancer | SWOG Cancer Research Network | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT05772871 Comparator | Apr 2023 → Sep 2025 | nephrotic syndrome | Jianhua Zhou | Unknown | No outcome recorded |
| Phase 4 | NCT00659997 Comparator | Jun → Sep 2006 | ascariasis, trichuriasis | Natural History Museum, United Kingdom | Completed | No outcome recorded |
Evidence & citations 18 cited values
Every value below carries the sentence it was read from. 26 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Levamisole | “Nitazoxanide, Chloroquine, Albendazole, Ivermectin, Mebendazole, Metronidazole, Praziquantel, Levamisole” NCT02366884 ↗19“Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients” NCT04049630 ↗ |
| Known as | Ascaridil | ChEMBL registry synonym — accepted as the source's own label CHEMBL1454 ↗ |
| Known as | Ergamisol | ChEMBL registry synonym — accepted as the source's own label CHEMBL1454 ↗ |
| Known as | Ketrax | ChEMBL registry synonym — accepted as the source's own label CHEMBL1454 ↗ |
| Known as | L-narpenol | ChEMBL registry synonym — accepted as the source's own label CHEMBL1454 ↗ |
| Known as | LEV | “A single dose of levamisole (LEV) induces a temporary, progressive MFD decrease.” PMID 40615414 ↗ Jul 2025 |
| Known as | levamisol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00309530 ↗ |
| Known as | Levamisole hcl | ChEMBL registry synonym — accepted as the source's own label CHEMBL1454 ↗ |
| Known as | levamisole hydrochloride | “levamisole hydrochloride” NCT00425152 ↗ |
| Known as | Levamisoli hydrochloridum | ChEMBL registry synonym — accepted as the source's own label CHEMBL1454 ↗ |
| Known as | NSC-177023 | “Arm II: Single-agent Chemotherapy with Drug Modulation plus Biological Response Modifier Therapy. 5-FU; with CF; plus Levamisole, LEV, NSC-177023.” NCT00425152 ↗ |
| Known as | R 12,564 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1454 ↗ |
| Known as | R 12654 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1454 ↗ |
| Known as | Solaskil | ChEMBL registry synonym — accepted as the source's own label CHEMBL1454 ↗ |
| Known as | Spartakon l | ChEMBL registry synonym — accepted as the source's own label CHEMBL1454 ↗ |
| Known as | TCMDC-125847 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1454 ↗ |
| Modality | Small molecule | “Levamisole 50 mg tablet” NCT04331470 ↗ |
| Route | Oral | “Patients also receive oral levamisole twice daily on days 1-3, 15-17, 29-31, and 43-45.” NCT00002551 ↗ |